These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9491829)

  • 21. [Serum kreatinkinase MB during fenoterol tocolysis (author's transl)].
    Steyer M; Rink K; Schlesing H; Morgenstern J; Heidenreich J
    Z Geburtshilfe Perinatol; 1979 Oct; 183(5):339-42. PubMed ID: 543183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of maternal side effects of various forms of intravenous therapy with fenoterol in premature labor].
    Herzog S; Cunze T; Osmers R; Kuhn W
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():73-9. PubMed ID: 8672931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-Agonist tocolytic therapy.
    Lam F; Gill P
    Obstet Gynecol Clin North Am; 2005 Sep; 32(3):457-84. PubMed ID: 16125044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the direct tocolytic action of salbupart and fenoterol in the treatment of imminent premature labour.
    Szczygielski A; Zbisławska P; Cretti A; Miadzielec T; Sznura E
    Mater Med Pol; 1988; 20(3):194-6. PubMed ID: 3244294
    [No Abstract]   [Full Text] [Related]  

  • 25. [Additional magnesium therapy in tocolysis: clinico-chemical monitoring parameters].
    Spätling L
    Geburtshilfe Frauenheilkd; 1984 Jan; 44(1):19-24. PubMed ID: 6559720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tocolysis for preterm labor: expert opinion.
    Hösli I; Sperschneider C; Drack G; Zimmermann R; Surbek D; Irion O;
    Arch Gynecol Obstet; 2014 Apr; 289(4):903-9. PubMed ID: 24385286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system.
    Freudenthaler SM; Schenck T; Lucht I; Gleiter CH
    Br J Clin Pharmacol; 1999 Oct; 48(4):631-4. PubMed ID: 10583037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Does tocolysis with fenoterol cause myocardial necrosis?].
    Meinen K
    Z Geburtshilfe Perinatol; 1983; 187(5):209-17. PubMed ID: 6359742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tocolysis: dangerous for the infant? Apropos of 1 case and review of the literature].
    Khelifati Y
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):252-6. PubMed ID: 11398001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of partusisten on the levels of human placental lactogen in the blood serum of pregnant women.
    Leszczyńska-Bystrzanowska J; Ossowski O; Krynicki E; Marianowski L; Korzycki J; Debski R
    Ginekol Pol; 1987 Sep; 58(9):573-6. PubMed ID: 3443353
    [No Abstract]   [Full Text] [Related]  

  • 31. Concentration-effect relationship of the positive chronotropic and hypokalaemic effects of fenoterol in healthy women of childbearing age.
    Bouillon T; Meineke I; Port R; Hildebrandt R; Günther K; Gundert-Remy U
    Eur J Clin Pharmacol; 1996; 51(2):153-60. PubMed ID: 8911881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficency of tocoylsis by fenoterol and fenoterol in combination with a beta-1-blocking compound (author's transl)].
    Trolp R; Irmer M; Bernius U; Pohl C; Steim H; Hillemanns HG
    Geburtshilfe Frauenheilkd; 1980 Jul; 40(7):602-9. PubMed ID: 7429136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The T/QRS ratio values in pregnancies complicated by threatened preterm labour treated with intravenous infusions of fenoterol.
    Fuchs T; Pomorski M; Grobelak K; Zimmer M
    J Perinat Med; 2015 Jul; 43(4):467-72. PubMed ID: 25153544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-limitation of intravenous tocolysis with beta2-adrenergic agonists is mediated through receptor G protein uncoupling.
    Frambach T; Müller T; Freund S; Engelhardt S; Sütterlin M; Lohse MJ; Dietl J
    J Clin Endocrinol Metab; 2005 May; 90(5):2882-7. PubMed ID: 15728216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medical tocolysis in threatening premature labor: what is safe in therapy?].
    Grospietsch G
    Gynakologe; 1991 Aug; 24(4):188-97. PubMed ID: 1682223
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indications for tocolysis. A prospective study].
    Zeller G; Dudenhausen JW
    Zentralbl Gynakol; 1986; 108(24):1473-81. PubMed ID: 3577451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The cardiac situation of newborn children after long-term tocolysis with fenoterol (author's transl)].
    Meinen K; Al-Issa H; Brienl H; Schmidt EW
    Geburtshilfe Frauenheilkd; 1981 Feb; 41(2):103-6. PubMed ID: 6908858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The treatment of premature labor with Partusisten].
    Hübschen K
    Med Welt; 1975 Jun; 26(24):1188-92. PubMed ID: 240101
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of the effectiveness of Partusisten and ethanol tocolysis. I: long-term tocolysis with Partusisten or ethanol].
    Förster F; During R
    Zentralbl Gynakol; 1987; 109(11):729-37. PubMed ID: 3114997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenetic treatment with tocolytic drugs of pregnant women with threatened premature labor].
    Murashko LE; Karibaeva BZh
    Akush Ginekol (Mosk); 1987 Oct; (10):30-4. PubMed ID: 2893558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.